LODATO, FRANCESCA
LODATO, FRANCESCA
LODATO F; F.LODATO; LODATO
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY
2009-01-01 F. Alessandrelli; F. Azzaroli; V. Feletti; A. Lisotti; F. Buonfiglioli; M. Montagnani; A. Colecchia; D. Festi; F. Lodato; E. Roda; G. Mazzella
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis
2006-01-01 Azzaroli F; Colecchia A; Lodato F; Trere D; Bacchi Reggiani ML; Festi D; Prati GM; Accogli E; Casanova S; Derenzini M; Roda E; Mazzella G
Adverse effects of proton pump inhibitors.
2010-01-01 Lodato F; Azzaroli F; Turco L; Mazzella N; Buonfiglioli F; Zoli M; Mazzella G.
Affidabilità della combinazione di angioecografia perfusionale ed altre tecniche di imaging nella valutazione della trombosi portale in pazienti con epatocarcinoma (HCC) candidati al trapianto di fegato
2007-01-01 Gianstefani A, Sagrini E, Ravaioli M., Morelli C, Lodato F, Quarneti C, Righini R, Pinna AD, Golfieri R, Bolondi L, Piscaglia F
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy
2016-01-01 Lodato, Francesca; Poluzzi, Elisabetta; Raschi, Emanuel; Piccinni, Carlo; Koci, Ariola; Olivelli, Valentina; Napoli, Chiara; Corvalli, Giulia; Nalon, Elena; De Ponti, Fabrizio; Zoli, Marco
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases.
2007-01-01 Festi D; Montagnani M; Azzaroli F; Lodato F; Mazzella G; Roda A; Di Biase AR; Roda E; Simoni P; Colecchia A.
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid.
2007-01-01 Azzaroli F.; Mennone A.; Feletti V.; Simoni P.; Baglivo E.; Montagnani M.; Rizzo N.; Pelusi G.; DE Aloysio D.; Lodato F.; Festi D.; Colecchia A.; Roda E.; Boyer J.L.; Mazzella G.
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation
2008-01-01 Lodato F; Berardi S; Gramenzi A; Mazzella G; Lenzi M; Morelli MC; Tame MR; Piscaglia F; Andreone P; Bologna Liver Transplantation Group (BLTG) [..; Ballardini G; Bernardi M; Bianchi FB; Biselli M; Bolondi L; Cescon M; Colecchia A; D'Errico A; Del Gaudio M; Ercolani G; Grazi GL; Grigioni W; Lorenzini S; Pinna AD; Ravaioli M; Roda E; Sama C; Vivarelli M.; ..]
CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis
2004-01-01 S. Giovanelli; A. D’Errico; F. Lodato; A. Colecchia; M.R. Tamé; F. Azzaroli; G. Vetrone; M. Del Gaudio; G.L. Grazi; E. Roda; G. Mazzella
Correlazione materno-fetale degli acidi biliari in corso di colestasi gravidica
2005-01-01 E. Baglivo; F. Azzaroli; M. Locatelli; V. Feletti; P. Simoni; G. Santarsiero; M. Franchina; N. Rizzo; Lodato; M. Montagnani; A. Colecchia; D. Festi; A. Roda; E. Roda; G. Mazzella
Effect of combined IFN-Alpha/Ribavirin Treatment in HCV disease-related progression
2008-01-01 D.Festi;F.Lodato;G.Mazzella;A.Colecchia
G-CSF administration is not related to PEG-IFN alfa-213 treatment duration nor response in liver transplanted patients with HCV recurrence
2008-01-01 Lodato F ; Tame MR ; Di Girolamo M ; Azzaroli F; Gramenzi A ; Berardi S ; Andreone P ; Pinna AD ; Roda E ; Mazzella G .
G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence
2009-01-01 Lodato F; Azzaroli F; Tamè MR; Di Girolamo M; Buonfiglioli F; Mazzella N; Cecinato P; Roda E; Mazzella G
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE
2009-01-01 Buonfiglioli f; Azzaroli F; Montagnani M;Simoni P; Locatelli M; Raspanti ME; Lisotti A; Lodato F; Alessandrelli F; Colecchia A; Festi D; Roda A; Roda E; Mazzella G
High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?
2007-01-01 Berardi S; Lodato F; Gramenzi A; D'Errico A; Lenzi M; Bontadini A; Morelli MC; Tamè MR; Piscaglia F; Biselli M; Sama C; Mazzella G; Pinna AD; Bernardi M; Andreone P.
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study
2005-01-01 Lodato F.; Azzaroli F.; Brillanti S.; Colecchia A.; Tame M.R.; Montagnani M.; Muratori R.; Giovanelli S.; Feletti V.; Bacchi Reggiani M.L.; Roda E.; Mazzella G.
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease
2011-01-01 Lisotti A, Azzaroli F, Turco L, Buonfiglioli F, Cecinato P, Calvanese C, Lodato F, Montagnani M, Golfieri R, Colecchia A, Festi D, Mazzella G
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease
2011-01-01 Lisotti A, Azzaroli F, Turco L, Buonfiglioli F, Ceciinato P, Calvanese C, Lodato F, Montagnani M, Golfieri R, Colecchia A, Festi D, Mazzella G
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease
2010-01-01 Lisotti A, Azzaroli F, Turco L, Buonfiglioli F, Simoni P, Cecinato P, Calvanese C, Lodato F, Montagnani M, Golfieri R, Colecchia A, Festi D, Mazzella G
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease.
2011-01-01 Lisotti A, Azzaroli F, Turco L, Buonfiglioli F, Cecinato P, Calvanese C, Lodato F, Montagnani M, Golfieri R, Colecchia A, Festi D, Mazzella G
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY | F. Alessandrelli; F. Azzaroli; V. Feletti; A. Lisotti; F. Buonfiglioli; M. Montagnani; A. Colecchia; D. Festi; F. Lodato; E. Roda; G. Mazzella | 2009-01-01 | JOURNAL OF HEPATOLOGY | - | 4.02 Riassunto (Abstract) | - |
| A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis | Azzaroli F; Colecchia A; Lodato F; Trere D; Bacchi Reggiani ML; Festi D; Prati GM; Accogli E; Casanova S; Derenzini M; Roda E; Mazzella G | 2006-01-01 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| Adverse effects of proton pump inhibitors. | Lodato F; Azzaroli F; Turco L; Mazzella N; Buonfiglioli F; Zoli M; Mazzella G. | 2010-01-01 | BAILLIERE'S BEST PRACTICE & RESEARCH. CLINICAL GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| Affidabilità della combinazione di angioecografia perfusionale ed altre tecniche di imaging nella valutazione della trombosi portale in pazienti con epatocarcinoma (HCC) candidati al trapianto di fegato | Gianstefani A, Sagrini E, Ravaioli M., Morelli C, Lodato F, Quarneti C, Righini R, Pinna AD, Golfieri R, Bolondi L, Piscaglia F | 2007-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy | Lodato, Francesca; Poluzzi, Elisabetta; Raschi, Emanuel; Piccinni, Carlo; Koci, Ariola; Olivelli, Valentina; Napoli, Chiara; Corvalli, Giulia; Nalon, Elena; De Ponti, Fabrizio; Zoli, Marco | 2016-01-01 | EUROPEAN JOURNAL OF INTERNAL MEDICINE | - | 1.01 Articolo in rivista | - |
| Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. | Festi D; Montagnani M; Azzaroli F; Lodato F; Mazzella G; Roda A; Di Biase AR; Roda E; Simoni P; Colecchia A. | 2007-01-01 | CURRENT CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. | Azzaroli F.; Mennone A.; Feletti V.; Simoni P.; Baglivo E.; Montagnani M.; Rizzo N.; Pelusi G.; DE Aloysio D.; Lodato F.; Festi D.; Colecchia A.; Roda E.; Boyer J.L.; Mazzella G. | 2007-01-01 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation | Lodato F; Berardi S; Gramenzi A; Mazzella G; Lenzi M; Morelli MC; Tame MR; Piscaglia F; Andreone P; Bologna Liver Transplantation Group (BLTG) [..; Ballardini G; Bernardi M; Bianchi FB; Biselli M; Bolondi L; Cescon M; Colecchia A; D'Errico A; Del Gaudio M; Ercolani G; Grazi GL; Grigioni W; Lorenzini S; Pinna AD; Ravaioli M; Roda E; Sama C; Vivarelli M.; ..] | 2008-01-01 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis | S. Giovanelli; A. D’Errico; F. Lodato; A. Colecchia; M.R. Tamé; F. Azzaroli; G. Vetrone; M. Del Gaudio; G.L. Grazi; E. Roda; G. Mazzella | 2004-01-01 | DIGESTIVE AND LIVER DISEASE | - | 4.02 Riassunto (Abstract) | - |
| Correlazione materno-fetale degli acidi biliari in corso di colestasi gravidica | E. Baglivo; F. Azzaroli; M. Locatelli; V. Feletti; P. Simoni; G. Santarsiero; M. Franchina; N. Rizzo; Lodato; M. Montagnani; A. Colecchia; D. Festi; A. Roda; E. Roda; G. Mazzella | 2005-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
| Effect of combined IFN-Alpha/Ribavirin Treatment in HCV disease-related progression | D.Festi;F.Lodato;G.Mazzella;A.Colecchia | 2008-01-01 | - | Springer | 2.01 Capitolo / saggio in libro | - |
| G-CSF administration is not related to PEG-IFN alfa-213 treatment duration nor response in liver transplanted patients with HCV recurrence | Lodato F ; Tame MR ; Di Girolamo M ; Azzaroli F; Gramenzi A ; Berardi S ; Andreone P ; Pinna AD ; Roda E ; Mazzella G . | 2008-01-01 | JOURNAL OF HEPATOLOGY | - | 4.02 Riassunto (Abstract) | - |
| G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence | Lodato F; Azzaroli F; Tamè MR; Di Girolamo M; Buonfiglioli F; Mazzella N; Cecinato P; Roda E; Mazzella G | 2009-01-01 | WORLD JOURNAL OF GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE | Buonfiglioli f; Azzaroli F; Montagnani M;Simoni P; Locatelli M; Raspanti ME; Lisotti A; Lodato F; Alessandrelli F; Colecchia A; Festi D; Roda A; Roda E; Mazzella G | 2009-01-01 | JOURNAL OF HEPATOLOGY | - | 4.02 Riassunto (Abstract) | - |
| High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? | Berardi S; Lodato F; Gramenzi A; D'Errico A; Lenzi M; Bontadini A; Morelli MC; Tamè MR; Piscaglia F; Biselli M; Sama C; Mazzella G; Pinna AD; Bernardi M; Andreone P. | 2007-01-01 | GUT | - | 1.01 Articolo in rivista | - |
| Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study | Lodato F.; Azzaroli F.; Brillanti S.; Colecchia A.; Tame M.R.; Montagnani M.; Muratori R.; Giovanelli S.; Feletti V.; Bacchi Reggiani M.L.; Roda E.; Mazzella G. | 2005-01-01 | JOURNAL OF VIRAL HEPATITIS | - | 1.01 Articolo in rivista | - |
| Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease | Lisotti A, Azzaroli F, Turco L, Buonfiglioli F, Cecinato P, Calvanese C, Lodato F, Montagnani M, Golfieri R, Colecchia A, Festi D, Mazzella G | 2011-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease | Lisotti A, Azzaroli F, Turco L, Buonfiglioli F, Ceciinato P, Calvanese C, Lodato F, Montagnani M, Golfieri R, Colecchia A, Festi D, Mazzella G | 2011-01-01 | JOURNAL OF HEPATOLOGY | - | 1.06 Abstract in rivista | - |
| Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease | Lisotti A, Azzaroli F, Turco L, Buonfiglioli F, Simoni P, Cecinato P, Calvanese C, Lodato F, Montagnani M, Golfieri R, Colecchia A, Festi D, Mazzella G | 2010-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. | Lisotti A, Azzaroli F, Turco L, Buonfiglioli F, Cecinato P, Calvanese C, Lodato F, Montagnani M, Golfieri R, Colecchia A, Festi D, Mazzella G | 2011-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |